Pharmaceutical formulations of potassium atp channel openers and uses thereof
AssigneeEssentialis, Inc.
InventorNeil Madison Cowen
Life of this patent
Estimating the term…
Abstract
Provided are immediate or prolonged administration of certain potassium ATP (KATP) channel openers to a subject to achieve novel pharmacodynamic, pharmacokinetic, therapeutic, physiological, metabolic and compositional outcomes in the treatment of diseases or conditions involving KATP channels. Also provided are pharmaceutical formulations, methods of administration and dosing of KATP channel openers that achieve these outcomes and reduce the incidence of adverse effects in treated individuals. Further provided are method of co-administering KATP channel openers with other drugs to treat diseases of humans and animals.
Claims20
1) A method of treating Prader Willi Syndrome comprising administering a pharmaceutical formulation of a KATP channel opener.
Dependencies are inferred from the claim text.